No Result
View All Result
  • Private Data
  • Membership options
  • Login
  • COUNTRY
    • ITALY
    • IBERIA
    • FRANCE
    • UK&IRELAND
    • BENELUX
    • DACH
    • SCANDINAVIA&BALTICS
  • PRIVATE EQUITY
  • VENTURE CAPITAL
  • PRIVATE DEBT
  • DISTRESSED ASSETS
  • REAL ESTATE
  • FINTECH
  • GREEN
  • PREMIUM
    • ItaHubHOT
      • ItaHub Legal
      • ItaHub Tax
      • ItaHub Trend
    • REPORT
    • INSIGHT VIEW
    • Private Data
Subscribe
  • COUNTRY
    • ITALY
    • IBERIA
    • FRANCE
    • UK&IRELAND
    • BENELUX
    • DACH
    • SCANDINAVIA&BALTICS
  • PRIVATE EQUITY
  • VENTURE CAPITAL
  • PRIVATE DEBT
  • DISTRESSED ASSETS
  • REAL ESTATE
  • FINTECH
  • GREEN
  • PREMIUM
    • ItaHubHOT
      • ItaHub Legal
      • ItaHub Tax
      • ItaHub Trend
    • REPORT
    • INSIGHT VIEW
    • Private Data
Home COUNTRY DACH

Gyrus Capital reaches the final closing of 700 million euros for Essential Pharma continuation fund

Salvatore Brunoby Salvatore Bruno
May 6, 2025
Reading Time: 3 mins read
in DACH, PRIVATE EQUITY, UK&IRELAND, Uncategorized
Gyrus Capital reaches the final closing of 700 million euros for Essential Pharma continuation fund
Share on FacebookShare on Twitter

In December 2024, the vehicle attracted 600 million from Alpinvest, StepStone, and other investor and carried on the recapitalization of the Pharma group that received a 300 million credit line from Sixth Street

Gyrus Capital said its continuation fund for its portfolio company Essential Pharma reached a final closing of 700 million euros as it attracted more than 100 million in commitments in 1Q25 (Private Equity Wire)  after having raised 600 million in December 2024 from lead investor AlpInvest (an asset of Carlyle,  StepStone Group, the company’s managers, and others (press release).

In December 2024, Essential Pharma, also attracted a strategic financing facility of 300 million from Sixth Street (press release).

Gyrus Capital acquired the UK pharmaceutical company in 2019 and supported its international growth. After such a new transaction and the refinancing of the debt structure, Essential will deploy additional capital to develop its diversified drug portfolio through a successful acquisition and development strategy that ceo Emma Johnson will lead.

Lee Morley, a non-executive director since 2023, will replace Patrick Vink as Essential Pharma chairman. Lee has an experience of more than 30 years in the biopharma sector and a thorough knowledge of marketing strategy, pricing, reimbursement and product launches. He cofounded and led EUSA Pharma, a company that Milan-listed Recordati, a portfolio asset of CVC Capital Partners, acquired in 2022 (see here previous post by BeBeez).

Continuation funds investment is a consolidated trend for the private equity industry. An increasing number of firms carried out the transfer from an old fund under closure to a new vehicle one or more investees that are not considered efficient to sell today at current prices, with a view to significant further business growth in the future. In previous years, such deals did not catch the keen interest of Limited Partners which considered these transactions as a way to find an allocation for troubled companies. However, sentiment has since changed, because indeed in recent years these funds creates additional value (see here the front page report of BeBeez Magazine of 1 March 2025).

The investors opinions about such transaction is not unanimous though. The Financial Times quoted Egyptian billionaire Nassef Sawiris  as saying: “Continuation funds are the biggest scam ever, because the firms buy back the businesses that can’t sell”.

Gateways to Italy

Gateways to Italy – Offer your services to funds and investors willing to explore opportunities in Italy. Become a partner!

Gateways to Italy – Offer your services to funds and investors willing to explore opportunities in Italy. Become a partner!

by Partner
June 6, 2023

Sign up to our newsletter

SIGN UP

Related Posts

FINTECH

British startup Assisterr raises €2.8 million to enable users to create and monetise AI agents – without having to write code

May 30, 2025
UK&IRELAND

Builder.ai faced US probe before company collapsed, reports say

May 30, 2025
DACH

Finnish & Swiss-founded Hedera Dx raises €15M Series A to expand precision cancer diagnostics in Europe

May 30, 2025

ItaHub

Crypto-assets supervision rules in Italy, Banca d’Italia will supervise payment systems and Consob on market abuse

Crypto-assets supervision rules in Italy, Banca d’Italia will supervise payment systems and Consob on market abuse

November 4, 2024
Italy’s SMEs export toward 260 bn euros in 2025

Italy’s SMEs export toward 260 bn euros in 2025

September 9, 2024
With two months to go before the NPL Directive, in Italy the securitization rebus is still to be unraveled

With two months to go before the NPL Directive, in Italy the securitization rebus is still to be unraveled

April 23, 2024
EU’s AI Act, like previous rules on technology,  looks more defensive than investment-oriented

EU’s AI Act, like previous rules on technology, looks more defensive than investment-oriented

January 9, 2024

Co-sponsor

Premium

Funds vying for management consulting firm BIP, a CVC portfolio company. All deals in the sector

Funds vying for management consulting firm BIP, a CVC portfolio company. All deals in the sector

March 6, 2025
Private equity, Italy 2024 closes with 588 deals as for investments and divestments from 549 in 2023. Here is the new BeBeez’s report

Private equity, Italy 2024 closes with 588 deals as for investments and divestments from 549 in 2023. Here is the new BeBeez’s report

February 10, 2025
Crypto-assets supervision rules in Italy, Banca d’Italia will supervise payment systems and Consob on market abuse

Crypto-assets supervision rules in Italy, Banca d’Italia will supervise payment systems and Consob on market abuse

November 4, 2024
Venture capital investments top €1.3bn in 208 rounds as of Sep30  in Italy. They were €1.5 in all 2023. The new BeBeez Report

Venture capital investments top €1.3bn in 208 rounds as of Sep30 in Italy. They were €1.5 in all 2023. The new BeBeez Report

October 28, 2024
Next Post
Panakès Partners leads deepull 50 million euros round

Italy’s angels & incubators and venture capital weekly roundup. News from depull, Panakès Partners, Columbus Venture Partners, Mérieux Equity Partners, MgShell, Capital Cell, Club degli Investitori, Italian Angels for Biotech, Bios Line, and more

Exclusive: GV backs AI startup StackOne in $20m funding round

EdiBeez srl

C.so Italia 22 - 20122 - Milano
C.F. | P.IVA 09375120962
Aut. Trib. Milano n. 102
del 3 aprile 2013

COUNTRY

Italy
Iberia
France
UK&Ireland
Benelux
DACH
Scandinavia&Baltics

CATEGORY

Private Equity
Venture Capital
Private Debt
Distressed Assets
Real Estate
Fintech
Green

PREMIUM

ItaHUB
Legal
Tax
Trend
Report
Insight view

WHO WE ARE

About Us
Media Partnerships
Contact

INFORMATION

Privacy Policy
Terms&Conditions
Cookie Police

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • COUNTRY
    • ITALY
    • IBERIA
    • FRANCE
    • UK&IRELAND
    • BENELUX
    • DACH
    • SCANDINAVIA&BALTICS
  • PRIVATE EQUITY
  • VENTURE CAPITAL
  • PRIVATE DEBT
  • DISTRESSED ASSETS
  • REAL ESTATE
  • FINTECH
  • GREEN
  • PREMIUM
    • ItaHub
      • ItaHub Legal
      • ItaHub Tax
      • ItaHub Trend
    • REPORT
    • INSIGHT VIEW
    • Private Data
Subscribe
  • Login
  • Cart